4th Annual ACDM Symposium on Artificial Intelligence (AI) in Clinical Trials
Cyntegrity is proud to announce our participation in the 4th Annual ACDM Symposium on Artificial Intelligence (AI) in Clinical Trials, taking place on June 23rd & 24th, 2025, in Frankfurt, Germany. Our CEO, Artem Andrianov, will be speaking at the event, sharing valuable insights on how AI is transforming the clinical trial landscape.
AI-TRIAL: A Collaborative Model Revolutionizing Clinical Trials
Our CEO, Artem Andrianov, will be a featured speaker, offering an in-depth presentation on AI-TRIAL, a groundbreaking project that has the potential to transform clinical trial management. As a collaborative initiative between Cyntegrity and the Fraunhofer Institute ITMP, AI-TRIAL aims to harness the power of AI-driven predictive modeling to optimize clinical trial outcomes. This symposium will highlight how the project leverages machine learning and predictive analytics to enhance key aspects of clinical trials, including:
- Patient Recruitment: Predicting the ideal patient population for a clinical trial by analyzing historical and real-time data, improving recruitment efficiency and reducing timelines.
- Safety Indicators: Using AI to monitor and analyze patient safety data, identifying potential issues early and mitigating risks.
- Protocol Adherence: Anticipating deviations from the trial protocol and implementing proactive measures to ensure compliance, enhancing the quality and reliability of trial data.
- Trial Metrics Forecasting: AI-TRIAL can predict critical trial metrics such as enrollment rates, retention, and overall performance up to twelve months in advance, providing trial sponsors and CROs with valuable foresight to optimize operations and resource allocation.
Don’t Miss This Opportunity!
This symposium also provides a chance to connect with industry leaders and explore collaboration opportunities in AI-driven clinical research. Join us in Frankfurt to discover how AI-TRIAL is shaping the future of clinical trials.
